Division for Cancer Pharmacology – Young Investigators Symposium
Monday April 06, 2020
4:00 pm
-
6:00 pm
Eastern Time (ET)
Room 17 A
DCP
Chair :
Andrew Thorburn
University of Colorado Anschutz Medical Campus
Jack Yalowich
Ohio State Univ
This session will feature oral presentations by young scientists that were selected from the submitted abstracts.
Speakers
Hengbo Zhou
- University of Colorado, Anschutz Medical Campus
Novel Small Molecule Compound disrupts the SIX1/EYA2 Complex and Inhibits Breast Cancer Metastasis
Megan Zavorka Thomas
- The Ohio State University
Gilteritinib Inhibits Acute Myeloid Leukemia Growth via Reduction in Glutamine Uptake and Utilization
Vrushank Bhatt
- Rutgers University
Autophagy Inhibition Sensitizes Liver Kinase B1 (LKB1)-Deficient Kras-Driven Lung Tumors to MEK Inhibitor Trametinib
Jae Yoon Jeon
- The Ohio State University
Activity of the Multikinase Inhibitor TP-0903 in RAS Mutant Acute Myeloid Leukemia
Dana Steffen
- University of California, San Diego
Gαs (GNAS) Suppression of the p53 Genomic-stability Checkpoint Unleashes RAS-driven Oncogenesis
An-Angela Van
- U.C. San Diego
Protein Kinase C Fusions Reveal Another Mechanism for Loss of Protein Kinase C Function in Cancer
Sanjay Varikuti
- The Ohio State University
Ibrutinib Treatment Inhibits Breast Cancer Progression and Metastasis by Inducing Conversion of Myeloid-derived Suppressor Cells to Dendritic Cells